April 24, 2024

#7 - Jon Greenwald: Conquering the Next Milestone

Listen and subscribe on your favorite platform

This episode features a conversation with Jon Greenwald.

With over two decades in healthcare and technology, Jon Greenwald is the co-founder and leader of Caira Surgical and has pioneered Radar Surgical Tracking and other innovative technologies to enhance joint replacement surgery. He has successfully launched and grown new businesses that leveraged proprietary technologies to transform industries that delivered top-line growth and profitability. In addition, he has secured and served as Principal Investigator on two $1M+ grants from the National Science Foundation to develop new surgical technologies. His areas of expertise include technology development, start-up and early-stage operations, commercialization, global supply chain and manufacturing, partnerships and alliances, non-dilutive funding, VC, and strategic partnerships.

Jon Greenwald’s interview provides a compelling look into his expansive career within the medical device sector, specifically his foundational role at Caira Surgical. Greenwald’s trajectory in medtech, particularly in orthopedics, reveals a depth of experience from his early days to his current endeavors in advancing surgical technology. His tenure is highlighted by a commitment to integrating innovative solutions such as Radar Surgical Tracking to enhance orthopedic surgery globally.

Greenwald speaks to the essence of innovation and the necessity of humility and continual learning in the ever-changing landscape of medical technology. His experiences underscore the importance of adaptability and strategic thinking, particularly in the startup ecosystem where he has thrived. Greenwald’s insights reflect a profound understanding of the industry’s challenges and the critical role of partnerships and networks in overcoming these hurdles and achieving significant milestones.

Throughout the discussion, Jon reiterates the value of a meticulous approach to both technology development and company growth, emphasizing his dedication to improving surgical outcomes through advanced technologies. This dedication not only underscores his leadership at Caira Surgical but also his broader impact on the medical device community, driven by a belief in the transformative power of medtech solutions in addressing complex health challenges.

As of April 2024, Caira Surgical is raising a $3MM bridge round. For more information, please reach out to Jon Greenwald at [email protected].

About this Guest

Jon Greenwald

Jon Greenwald brings a wealth of experience to the medical device sector, with significant contributions at both startup and established companies. Jon’s career highlights include leadership roles at Caira Surgical, where he has been pivotal from inception through its growth phases. His expertise spans the development and commercialization of innovative surgical technologies, particularly in orthopedics.

Explore Other Episodes

#6 – Mark Christopherson: Persevering Through The Doubters

This podcast episode features a conversation with Mark Christopherson. Mark Christopherson brings over three decades of expertise to the forefront of the medical device industry, with pivotal roles at Medtronic and leadership in venture-backed startups. Mark’s track record includes foundational roles at Inspire Medical and Cryosa, where he was instrumental from the startup phase through commercialization.

Read More »

#10 – Max Ostermeier: Minimizing Uncertainty

Max G. Ostermeier (MBA) is the co-founder and General Manager of Implandata Ophthalmic Products GmbH. He brings extensive experience in the commercial development of advanced technologies, building operational capabilities for rapidly growing companies, and creating businesses that attract global acquirers.

As a serial entrepreneur, Max founded and managed Odicrain GmbH, a German medical device start-up that developed a pioneering portable device for the rapid detection of intracranial bleedings, which was acquired by a US-based company in 2007. He also co-founded and served as CEO of Cranium Telemetrics GmbH, a medical technology company specializing in innovative neurosurgical products, which was acquired by a leading US medical device company four years after its founding. Additionally, Max played a key role in establishing a biotech entity for a globally leading fine chemistry company, where he served as General Manager and Vice-President until its acquisition by Sigma Aldrich.

Read More »

#11 – Dr. Neel Patel: Democratizing Medical Testing & Health Data

Dr. Neel Patel is the co founder and CEO of Zio Health, a medtech company based in London, UK. After a career of being a physician, he stated ZiO Health and worked towards a shared goal with his team: bringing hospital-grade lab testing to the point-of-use, enhancing accessibility to molecular testing and optimizing health and sickness prevention. More specifically, they have developed a point-of-care therapeutic drug monitoring device which measures medication concentration levels to improve drug treatment outcomes.
Dr. Patel is also a Partner at HealthTech Investors, an angel syndicate that invests in founders working on the best solutions in improving healthcare.

Read More »

Join our newsletter for regular updates on the podcast, USD Discovery District, and medtech and life science related insights.

By submitting your email to subscribe, you agree to our Privacy Policy.

Proudly Sponsored By